Moving forward, how much more is our former CEO going to dump? Now that he’s unchained, how many of his Class B shares will he swap into Class A? Insider selling is the absolute biggest risk for this company!!
From my experience as a long-time stock investor..... Companies whose IR teams fail to communicate effectively with the outside world rarely have a bright future.
What everyone should be concerned about is the industry's reaction to the FDA's uncertainty. Although compelling Phase 2 data for the FAP treatment was reported, approaching the FDA seems like it will be difficult until 'the dust settles.' What on earth does 'the dust settling' even look like at this point? Will it be positive for Rec-4881?
A company where the Investor Relations team is just slacking off. A company that thinks taciturnity and silence are virtues. I wish they were even half as good as Insilico Medicine..
A company that doesn't even realize its stock price is tanking as a result.Look at that, insider selling just keeps continuing today without end.